In lung adenocarcinoma, GBP1 boosts cell motility and invasiveness by binding beta-tubulin, increasing metastatic potential to distant sites such as lymph nodes, bones, or the brain, a process linked to its plasma membrane localization and GTPase activity [18]. Here, GBP1 is linked to lung adenocarcinoma.